| ²é¿´: 630 | »Ø¸´: 3 | ||
| ±¾Ìû²úÉú 1 ¸ö LS-EPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
ÕÜÄýľ³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇóÖúĬ¿ËË÷ÒýÏà¹ØÐÅÏ¢£¬Ð»Ð»´ó¼Ò
|
|
|
ÇóÖúĬ¿ËË÷ÒýÏà¹ØÐÅÏ¢£¬Ð»Ð»´ó¼Ò£¬¿É×·¼Ó½ð±Ò£º Ó¢ÎÄͨÓÃÃû£ºIxabepilone ÖÐÎÄͨÓÃÃû£ºÒÁɳƥ¡ ÉÌÆ·Ãû£º Ixempra CASµÇ¼ºÅ£º219989-84-1 |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸211 0703»¯Ñ§ 346·ÖÇóµ÷¼Á
ÒѾÓÐ26È˻ظ´
ÉúÎïѧµ÷¼Á
ÒѾÓÐ13È˻ظ´
293Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
335Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
È˹¤ÖÇÄÜ320µ÷¼Á08¹¤À໹Óлú»áÂð
ÒѾÓÐ14È˻ظ´
271Çóµ÷¼Á
ÒѾÓÐ27È˻ظ´
¿¼ÑÐÇóµ÷¼Á
ÒѾÓÐ7È˻ظ´
085408¹âµçÐÅÏ¢¹¤³Ìר˶355Ò»Ö¾Ô¸³¤´º¹â»úËùµ÷¼Á
ÒѾÓÐ3È˻ظ´
071000ÉúÎïѧ£¬Ò»Ö¾Ô¸ÉîÛÚ´óѧ296·Ö£¬Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
302Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
leyi1504
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 563.3
- É¢½ð: 5
- ºì»¨: 2
- Ìû×Ó: 67
- ÔÚÏß: 90.8Сʱ
- ³æºÅ: 1559956
- ×¢²á: 2012-01-02
- ÐÔ±ð: GG
- רҵ: »úе¶¯Á¦Ñ§

4Â¥2014-03-04 15:04:27
baiyuefei
°æÖ÷ (ÎÄѧ̩¶·)
·çÑ©
- LS-EPI: 1647
- Ó¦Öú: 4642 (¸±½ÌÊÚ)
- ¹ó±ö: 46.97
- ½ð±Ò: 658713
- É¢½ð: 11616
- ºì»¨: 995
- ɳ·¢: 81
- Ìû×Ó: 69434
- ÔÚÏß: 13334.2Сʱ
- ³æºÅ: 676696
- ×¢²á: 2008-12-18
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
- ¹ÜϽ: Óлú½»Á÷
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
ÕÜÄý: ½ð±Ò+10, ¡ï¡ï¡ïºÜÓаïÖú, лл 2013-09-16 22:22:52
jssxh: ½ð±Ò+3, ¼ìË÷EPI+1, лл²ÎÓ룬Çë¼ÌÐø¹Ø×¢±¾°æ¿é£¡ 2014-03-05 11:48:12
ÕÜÄý: ½ð±Ò+10, ¡ï¡ï¡ïºÜÓаïÖú, лл 2013-09-16 22:22:52
jssxh: ½ð±Ò+3, ¼ìË÷EPI+1, лл²ÎÓ룬Çë¼ÌÐø¹Ø×¢±¾°æ¿é£¡ 2014-03-05 11:48:12
|
Title: Ixabepilone CAS Registry Number: 219989-84-1 CAS Name: (1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione Additional Names: azaepothilone B Manufacturers' Codes: BMS-247550; NSC-710428 Molecular Formula: C27H42N2O5S Molecular Weight: 506.70 Percent Composition: C 64.00%, H 8.35%, N 5.53%, O 15.79%, S 6.33% Literature References: Microtubule stabilizing semisynthetic lactam analog of epothilone B, q.v. Prepn: G. D. Vite et al., WO 9902514; eidem, US 6605599 (1999, 2003 both to Bristol-Myers Squibb); R. M. Borzilleri et al., J. Am. Chem. Soc. 122, 8890 (2000). Antineoplastic activity in vitro and in vivo: F. Y. F. Lee et al., Clin. Cancer Res. 7, 1429 (2001). Clinical evaluation with estramustine in prostate cancer: J. E. Rosenberg et al., Cancer 106, 58 (2006). Clinical pharmacokinetics and evaluation in solid tumors: S. Mani et al., Clin. Cancer Res. 10, 1289 (2004). Clinical evaluation in breast cancer: J. A. Low et al., J. Clin. Oncol. 23, 2726 (2005); in prostate cancer: M. Hussain et al., ibid. 8724. Review of pharmacology and clinical development: N. Lin et al., Curr. Opin. Invest. Drugs 4, 746-756 (2003). Properties: Colorless oil or white lyopholizate; [a]D22 -40.7¡ã (c = 1.0 in chloroform). Optical Rotation: [a]D22 -40.7¡ã (c = 1.0 in chloroform) Therap-Cat: Antineoplastic. Keywords: Antineoplastic; Alkaloids/Natural Products. |
2Â¥2013-09-16 22:05:41
ÕÜÄý
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 16 (СѧÉú)
- ½ð±Ò: 1671.2
- Ìû×Ó: 106
- ÔÚÏß: 155.4Сʱ
- ³æºÅ: 2580784
- ×¢²á: 2013-08-04
- ÐÔ±ð: GG
- רҵ: Ò©Îﻯѧ
3Â¥2013-09-16 22:24:09













»Ø¸´´ËÂ¥